Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Mar 15, 2023; 15(3): 464-489
Published online Mar 15, 2023. doi: 10.4251/wjgo.v15.i3.464
Published online Mar 15, 2023. doi: 10.4251/wjgo.v15.i3.464
Figure 7 Xiaojianzhong decoction inhibited Unc-51 Like kinase 1 and p53/AMP-activated protein kinase pathway in N-methyl-N’-nitro-N-nitrosoguanidine-induced gastric precancerous lesions rats.
A and B: Unc-51 like kinase 1 (ULK1) and p53 protein expression was determined using immunofluorescence (n = 5); ULK1, p53 proteins positive score was determined using Image J; C: ULK1 mRNA expression was determined using real-time polymerase chain reaction analysis (n = 3); D-G: Western blot analysis was performed to detect p-p53, p-AMP-activated protein kinase, p-ULK1 (Ser555), and p-ULK1 (Ser317) protein expression (n = 3); H and I: ULK1 and p53 protein expression was determined using immunofluorescence (n = 5). Data are expressed as mean ± SD. aP < 0.05, bP < 0.01, cP < 0.001 vs control group; dP < 0.05, eP < 0.01, fP < 0.001 vs model group. XJZ-L: Low dose of Xiaojianzhong decoction; XJZ-M: Middle dose of Xiaojianzhong decoction; XJZ-H: High dose of Xiaojianzhong decoction; ULK1: Unc-51 like kinase 1.
- Citation: Zhang JX, Bao SC, Chen J, Chen T, Wei HL, Zhou XY, Li JT, Yan SG. Xiaojianzhong decoction prevents gastric precancerous lesions in rats by inhibiting autophagy and glycolysis in gastric mucosal cells. World J Gastrointest Oncol 2023; 15(3): 464-489
- URL: https://www.wjgnet.com/1948-5204/full/v15/i3/464.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i3.464